Nikolaj Frost

Has grant

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

ANTELOPE

Open Date: 2022-09-01

Close Date: 2025-12-01

Articles (28)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (22)

Ulrike Grittner

Charité - Universitätsmedizin Berlin

GERMANY

View details

Christian Furth

GERMANY

View details

Simon Schallenberg

GERMANY

View details

Tomasz Dziodzio

Charité - Universitätsmedizin Berlin

GERMANY

View details

Zoe Shaked

Charité - Universitätsmedizin Berlin

GERMANY

View details

Anja Kühl

Head & PI /Ph.D.

Charité - Universitätsmedizin Berlin

GERMANY

View details

Helena Radbruch

Charité - Universitätsmedizin Berlin

GERMANY

View details

Samuel Knauss

GERMANY

View details

Raphael Mohr

Charité - Universitätsmedizin Berlin

GERMANY

View details

Robert Öllinger

Professor

Charité - Universitätsmedizin Berlin

GERMANY

View details

Jens C. Rueckert

Charité - Universitätsmedizin Berlin

GERMANY

View details

Thomas Reinhold

Charité - Universitätsmedizin Berlin

GERMANY

View details

Stefan Frischbutter

Head of Basic Science

Charité Universitätsmedizin Berlin Campus Benjamin Franklin

GERMANY

View details

Hans-Georg Kopp

Head of Department

Robert Bosch Center for Tumor Diseases

GERMANY

View details

Tommaso Araceli

University Hospital Regensburg

GERMANY

View details

Ramin Raul Ossami Saidy

Charité - Universitätsmedizin Berlin

GERMANY

View details

Christine Holmberg

Professor

Medizinische Hochschule Brandenburg Theodor Fontane

GERMANY

View details

Ronald Simon

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Peter Vajkoczy

Charité - Universitätsmedizin Berlin

GERMANY

View details

Felix Hehnen

Deutsches Herzzentrum der Charité

GERMANY

View details

Lars Bullinger

Charité University Medicine

GERMANY

View details

Alberto Lopez-Pastorini

University Hospital

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nikolaj Frost

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (28)

Clinical characteristics and outcomes in leptomeningeal disease with or without brain metastasis: insights from an explorative data analysis of the Charité LMD registry.

TTF-1 negativity in synchronous M1b/M1c wildtype lung adenocarcinoma brain metastases predicts worse survival with increased risk of intracranial progression.

Re-resection of brain metastases – outcomes of an institutional cohort study and literature review

Practice Variation in Perioperative Dexamethasone Use and Outcomes in Brain Metastasis Resection.

Non-Small Cell Lung Cancer Patients with Skip-N2 Metastases Have Similar Survival to N1 Patients—A Multicenter Analysis

Treatment of NSCLC after chemoimmunotherapy — are we making headway?

Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection.

Non–Small Cell Lung Cancer Metastatic Without Oncogenic Alterations

Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer

Corrigendum to “First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations” [Eur J Cancer 199 (2024) 113556] (European Journal of Cancer (2024) 199, (S0959804924000327), (10.1016/j.ejca.2024.113556))

Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma,Kriterien für die Behandlung von thoraxonkologischen Erkrankungen als stationäre Leistung bei Erwachsenen

First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations.

Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany.

TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading.

Erratum: Criteria for inpatient diagnostic and treatment of patients with lung cancer, mesothelioma or thymoma (Pneumologie (Stuttgart, Germany) (2024) 78 4 (233-235)),Erratum: Kriterien für die Behandlung von thoraxonkologischen Erkrankungen als stationäre Leistung bei Erwachsenen

TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities

Perioperative Nivolumab in Resectable Lung Cancer.

Feasibility of a patient-oriented navigation programme for patients with lung cancer or stroke in Germany: Protocol of the CoreNAVI study.

Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative, Metastatic Lung Adenocarcinoma (AIO-TRK-0122)

Besonderheiten in der Therapie des TTF-1-negativen Adenokarzinoms der Lunge

Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer – A multicenter observational analysis

A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [18 F]FDG-PET/CT parameters.

Immune signatures of checkpoint inhibitor-induced autoimmunity—A focus on neurotoxicity

Reducing Immunosuppression in Patients with De Novo Lung Carcinoma after Liver Transplantation Could Significantly Prolong Survival

Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients’ Blood

Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR

Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment - A multicenter analysis.

[Immunotherapy for non-small cell lung cancer (NSCLC)].

Collaborators (22)

Ulrike Grittner

Christian Furth

Simon Schallenberg

Tomasz Dziodzio

Zoe Shaked

Anja Kühl

Helena Radbruch

Samuel Knauss

Raphael Mohr

Robert Öllinger

Jens C. Rueckert

Thomas Reinhold

Stefan Frischbutter

Hans-Georg Kopp

Tommaso Araceli

Ramin Raul Ossami Saidy

Christine Holmberg

Ronald Simon

Peter Vajkoczy

Felix Hehnen

Lars Bullinger

Alberto Lopez-Pastorini

Make your next move.